Paper42005709
Research Progress and Preclinical Prospects of Plant-Derived Extracellular Vesicles in Targeted Delivery of Antitumor Drugs.
Huang D and 7 others. Int J Nanomedicine, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Research Progress and Preclinical Prospects of Plant-Derived Extracellular Vesicles in Targeted Delivery of Antitumor Drugs. Papers, record 42005709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Research Progress and Preclinical Prospects of Plant-Derived Extracellular Vesicles in Targeted Delivery of Antitumor Drugs.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| Antineoplastic Agents | Major topic |
| Drug Delivery Systems | Major topic |
| Plants | Major topic |
| Humans | |
| Animals | |
| Tumor Microenvironment | |
| Neoplasms | |
| Drug Carriers |
Source PubMed
References119
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36986835 | Plant-Derived Extracellular Vesicles as a Delivery Platform for RNA-Based Vaccine: Feasibility Study of an Oral and Intranasal SARS-CoV-2 Vaccine. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986835 | PubMed |
| 2 | 37687011 | Momordica charantia-Derived Extracellular Vesicles Provide Antioxidant Protection in Ulcerative Colitis. | Molecules | 2023 | https://conductscience.org/library/papers/37687011 | PubMed |
| 3 | 36736944 | Nicotine's effect on cognition, a friend or foe? | Prog Neuropsychopharmacol Biol Psychiatry | 2023 | https://conductscience.org/library/papers/36736944 | PubMed |
| 4 | 36519808 | Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. | J Extracell Vesicles | 2022 | https://conductscience.org/library/papers/36519808 | PubMed |
| 5 | 34990792 | Technology insight: Plant-derived vesicles-How far from the clinical biotherapeutics and therapeutic drug carriers? | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/34990792 | PubMed |
| 6 | 40139523 | Plant extracellular vesicles as emerging neuroprotective agents for central nervous system disorders. | J Adv Res | 2026 | https://conductscience.org/library/papers/40139523 | PubMed |
| 7 | 33411885 | Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer. | Endocrinology | 2021 | https://conductscience.org/library/papers/33411885 | PubMed |
| 8 | 36400817 | Comparison of two isolation methods of tobacco-derived extracellular vesicles, their characterization and uptake by plant and rat cells. | Sci Rep | 2022 | https://conductscience.org/library/papers/36400817 | PubMed |
| 9 | 37958646 | Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming-The Potential Role of Ascorbic Acid. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958646 | PubMed |
| 10 | 31775862 | Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31775862 | PubMed |
| 11 | 37984504 | Therapeutic potential of plant-derived extracellular vesicles as nanocarriers for exogenous miRNAs. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/37984504 | PubMed |
| 12 | 39634409 | Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport. | Heliyon | 2024 | https://conductscience.org/library/papers/39634409 | PubMed |
| 13 | 39978779 | Plant-derived extracellular vesicles as nanocarriers for combination therapy enhancing paclitaxel-based regimens in breast cancer. | BMB Rep | 2025 | https://conductscience.org/library/papers/39978779 | PubMed |
| 14 | 36196516 | Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics. | Plant Signal Behav | 2022 | https://conductscience.org/library/papers/36196516 | PubMed |
| 15 | 40134377 | Progress of research on engineered extracellular vesicles from different sources for disease treatment. | Histol Histopathol | 2025 | https://conductscience.org/library/papers/40134377 | PubMed |
| 16 | 39967127 | Colonic delivery and controlled release of curcumin encapsulated within plant-based extracellular vesicles loaded into hydrogel beads. | Food Res Int | 2025 | https://conductscience.org/library/papers/39967127 | PubMed |
| 17 | 39062803 | A Systematic Review on Plant-Derived Extracellular Vesicles as Drug Delivery Systems. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062803 | PubMed |
| 18 | 38765146 | Plant-derived exosome-like nanovesicles: A novel nanotool for disease therapy. | Heliyon | 2024 | https://conductscience.org/library/papers/38765146 | PubMed |
| 19 | 39286353 | Multiomic Profiling and Neuroprotective Bioactivity of Salvia Hairy Root-Derived Extracellular Vesicles in a Cellular Model of Parkinson's Disease. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39286353 | PubMed |
| 20 | 27837092 | Extracellular Vesicles Isolated from the Leaf Apoplast Carry Stress-Response Proteins. | Plant Physiol | 2017 | https://conductscience.org/library/papers/27837092 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42846158 | Ginger-Derived Nanoparticles Deliver a VEGFA-Targeting DNAzyme and Modulate Retinal VEGFA Expression and Inflammatory Markers in Experimental Diabetic Retinopathy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42846158 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42005709
GET https://conductscience.org/api/papers/v1/42005709/references?page=2